Midlife Women's Health 2024: A Multidisciplinary Approach to Care

May 10, 2024


Midlife Women’s Health 2024 provides a multi-disciplinary approach to the care of menopausal women. Advances in research, technology, and pharmacology increase options available for midlife women, but this rapidly changing knowledge-base presents a challenge for clinicians. Care for women at this stage of life is optimized by education on a range of medical concerns provided by experts from a wide variety of medical specialties. Given demographic changes in the US population, midlife women are becoming an increasingly important group served by health care professionals, with needs that cross many areas of medical expertise.

In this educational activity, a multidisciplinary group of experts from Massachusetts General Hospital will present on the evaluation and management of gynecologic cancers, vascular disease, parathyroid disease and thyroid nodules, vulvovaginal disorders, lung cancer, cardiovascular health, attention deficit hyperactivity disorder, sexuality after cancer, and menopausal hormone therapy to assist clinicians in caring for their midlife patients. 

Target Audience

This educational activity is intended for physicians and advance practice nurses in primary care, gynecology, general surgery, internal medicine, endocrinology, psychiatry, gynecological oncology, cardiology, and preventive medicine who provide care to midlife women. Physicians and advance practice nurses in-training also are encouraged to attend.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Identify signs and symptoms of gynecologic cancers at midlife to optimize outcomes.
  2. Employ a greater understanding of vascular disease in aging women to reduce disease burden.
  3. Evaluate parathyroid disease and thyroid nodules in aging women.
  4. Assess midlife women for vulvovaginal disorders and guide the use of available treatment options.
  5. Recognize the link between stress, inflammation, and cardiovascular disease in women to improve health.
  6. Assess midlife women for attention deficit hyperactivity disorder and utilize effective therapies.
  7. Formulate a strategy to identify women at increased risk of lung cancer to optimize care.
  8. Integrate behavioral and pharmacologic strategies to improve sexual function for cancer survivors.
  9. Evaluate symptomatic midlife women for menopausal hormone therapy, incorporating an individualized assessment of risks and benefits.

Additional Information

Provided by: 

Massachusetts General Hospital - Department of OB/GYN & Mass General Brigham

Course summary
Available credit: 
  • 7.75 AMA PRA Category 1 Credit™
  • 7.75 Participation
Course opens: 
Course expires: 
Event starts: 
05/10/2024 - 7:45am EDT
Event ends: 
05/10/2024 - 5:00pm EDT

7:45 AM

Welcome & Introductory Remarks
Jan Shifren, MD & Jeffrey Ecker, MD


Gynecologic Cancers: Update for 2024
Allison Gockley, MD & Varvara Mazina, MD


Vascular Disease: Evaluation and Treatment in Older Women
Anahita Dua, MD, MS, MBA


Parathyroid Disease and Thyroid Nodules: Diagnosis and Management
Rajshri Gartland, MD, MPH




Vulvovaginal Disorders at Midlife: Beyond the Genitourinary Syndrome of Menopause
Alisa Pascale, DNP, WHNP-BC


Stress, Inflammation & Cardiovascular Disease: Understanding the Link in Aging Women
Ahmed Tawakol, MD

12:00 PM

Lunch Break


Beyond Adolescence - Impact of Attention Deficit Hyperactivity Disorder in Midlife Women
Allison Baker, MD


Lung Cancer in Women: Optimizing Identification & Treatment
Lecia Sequist, MD, MPH


Sexuality after Cancer
Don Dizon, MD




Menopausal Hormone Therapy - Risks, Benefits & Alternatives
Deborah Kwolek, MD


Everything You Wanted to Know About Menopause, but Were Afraid to Ask
Isaac Schiff, MD, Linda Kelly, DNP, ANP-BC & Deborah Kwolek, MD

5:00 PM



Jan L. Shifren, MD - Course Director
Jan L. Shifren, MD is a reproductive endocrinologist at the Massachusetts General Hospital and Director of the MGH Midlife Women’s Health Center. She is the Vincent Trustees Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. Dr. Shifren focuses her research on menopause, including the effects of estrogens, androgens and alternative therapies on menopausal symptoms and sexual function. She is a past President of the Menopause Society.

Allison Baker, MD
Allison Baker, MD is a psychiatrist with the Perinatal and Reproductive Psychiatry Clinical Research Program at the Massachusetts General Hospital and an Instructor in Psychiatry at Harvard Medical School. Her current research focuses on the course and treatment of ADHD in women during pregnancy and postpartum.

Don Dizon, MD
Don Dizon, MD is the Director of the Pelvic malignancies Program at Lifespan Cancer Institute, Head of Community Outreach & Engagement at Legorreta Cancer Center, and the Director of Medical Oncology at Rhode Island Hospital. Nationally, he is the Vice Chair for Diversity, Equity, Inclusion, and Professional Integrity at SWOG Cancer Research Network. He also is a founding member of the Collaboration for Outcomes using Social Media in Oncology. His research foci include novel treatment of ovarian, uterine, and cervical cancers; communication; survivorship after cancer especially in sexuality; professional social media use; and advocacy on behalf of the sexual and gender minoritized communities.

Anahita Dua, MD, MS, MBA
Anahita Dua, MD, MS, MBA is a vascular surgeon at the Massachusetts General Hospital and an Associate Professor of Surgery at Harvard Medical School. At MGH, she is the director of the Vascular Lab, co-director of the Peripheral Artery Disease Center and Limb Evaluation and Amputation Program, associate director of the Wound Care Center, director of the Lymphedema Center, associate director of the Vascular Surgery Clerkship, and director of clinical research for the division of vascular surgery.

Rajshri Gartland, MD, MPH
Rajshri Gartland, MD, MPH is an endocrine surgeon and surgical oncologist at the Massachusetts General Hospital with expertise in the surgical treatment of benign and malignant thyroid, parathyroid, and adrenal diseases. Dr. Gartland's clinical and research interests focus on the practice and advancement of endocrine surgery, particularly through innovative and minimally-invasive techniques. She co-founded and leads the Thyroid Radiofrequency Ablation Program at MGH and serves as Surgical Director of the NWH Thyroid Biopsy Clinic and Assistant Chief Quality Officer at MGH.

Allison Gockley, MD
Allison Gockley, MD is a gynecologic oncologist in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital. Dr. Gockley’s research interests include the surgical treatment of gynecologic cancers, gestational trophoblastic neoplasia, advanced endometrial cancer and onco-fertility.

Linda Kelly, DNP, ANP-BC
Linda Kelly, DNP, ANP-BC is an advanced practice provider at the Massachusetts General Hospital. She is the Nursing Director of the Midlife Women's Health Center in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital.

Deborah Kwolek, MD
Deborah Kwolek, MD is a primary care physician at the Massachusetts General Hospital and the founding lead of the Women’s Health and Sex and Gender Medicine Program at the MGH and Harvard Medical School. Dr Kwolek is co-editor of the textbook, Sex- and Gender-Based Women’s Health: A Practical Guide for Primary Care. She is Chair of the Society of General Internal Medicine’s Women and Medicine Commission and serves as Co-Chair of the American Medical Women’s Association’s Sex and Gender Health Collaborative’s mentoring committee. Dr. Kwolek directs the HMS Primary Care Internal Medicine Course and the Women's Health Resident Rotation at MGH.

Varvara Mazina, MD
Varvara Mazina, MD is a gynecologic oncologist in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital. Dr. Mazina’s research interests include multidisciplinary and translational collaboration for management of gynecologic malignancies, surgical innovation and education, and improvement of quality of life of cancer patients and survivors. 

Alisa Pascale, DNP, WHNP-BC
Alisa Pascale, DNP, WHNP-BC is a women's health nurse practitioner in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital. Her clinical interests include routine gynecologic care across the lifespan, contraceptive management, perimenopausal issues and LGBTQ health. She has clinical expertise in vulvar and vaginal disorders, including chronic vaginitis, and vulvar skin disorders such as lichen sclerosis. Dr. Pascale is a clinical instructor in the Women's Health program at the MGH Institute of Health Professions. 

Isaac Schiff, MD
Isaac Schiff, MD is the Chief, Department of Obstetrics and Gynecology, Emeritus, at the Massachusetts General Hospital and the Joe Vincent Meigs Distinguished Professor of Gynecology at Harvard Medical School. He is Co-Director of the MGH Midlife Women’s Health Center. Dr. Schiff is an internationally known expert in menopause, a founding member of the Menopause Society, and the Editor-in-Chief of the journal, Menopause.

Lecia Sequist, MD, MPH
Lecia Sequist, MD, MPH is a medical oncologist in the Center for Thoracic Cancers at the Massachusetts General Hospital and Program Director, Cancer Early Detection and Diagnostics Clinic. She holds the Mary B Saltonstall Endowed Chair in Oncology at MGH and is the Landry Family Professor of Medicine at Harvard Medical School. Dr. Sequist's research focuses on studying novel targets and targeted agents for lung cancer treatment and in detecting and studying the significance of tumor cells circulating in the bloodstream.

Ahmed Tawakol, MD
Ahmed Tawakol, MD is a cardiologist at the Massachusetts General Hospital. He is Co-Director of the Cardiac MR PET CT Program. Dr. Tawakol's research focuses on developing novel diagnostic approaches and treatment strategies for atherosclerosis. He leads several multi-center trials to evaluate interventions targeting plaque inflammation and is evaluating the potential clinical role of vascular PET imaging for improving the identification of patients at highest risk for atherothrombotic events.

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Mass General Brigham designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 7.75 AMA PRA Category 1 Credit™
  • 7.75 Participation


Please login or register to take this course.
Registration TypeTuition Fee
Other Health Care Professionals & Physicians-in-Training$125

AFTER MARCH 29, 2024
Registration TypeTuition Fee
Other Health Care Professionals & Physicians-in-Training$150

Cancellation Policy:
Registrations cancelled on or before March 29, 2024 will be refunded, less a $35 administrative fee. Registrations cancelled after March 29, 2024 will not be refunded.

Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.

Please contact our Course Coordinator at MGHMidlifeCenter@mgh.harvard.edu prior to the event to assist you with any special needs.